Jazz Pharmaceuticals plc (JAZZ) short interest & options flow
NASDAQJazz Pharmaceuticals reports Q3 results on November 4 with a notable reversal from the positioning that preceded yesterday's earlier earnings date: options traders have swung sharply toward protection, while short interest remains elevated at 9.2% of the free float. The clearest change since the prior preview is in options. The put/call ratio jumped to 0.89 on November 2, more than…
JAZZ short interest surges 26.6% in one day to 8.1% of float, marking highest spike in week as 4.95M shares now borrowed.
- Market cap
- $15.04B
- Next earnings
- 24 Feb 2027
Key data as of 5 Nov 2026
JAZZ news and analysis
RSSNo long-form analysis yet for JAZZ. Pulse alerts and the live data picture are available on ORTEX.
Open JAZZ on ORTEX →Want the live picture for JAZZ?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JAZZ — free to start on ORTEX.
Sign up for free →Open JAZZ on ORTEX